Justin Petrone
Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
Articles Authored by Justin Petrone
The €4.5 million ($4.2 million) effort is led by researchers from Sweden's Karolinska Institute and aims to deliver lateral flow tests and point-of-care devices.
Mursla Bio, a Cambridge, UK-based company that focuses on EV isolation, biomarker discovery from EV cargo, and EV assays for clinical use, is an EVEREST participant.
The company, based outside of Grenoble in the French Alps, together with its partners has received €5 million to pursue the project.
Next Implementation Steps Unclear After EU Parliament Votes to Support IVD Regulation Review
Premium
The parliamentary resolution drew the immediate support of MedTech Europe and VDGH, but it remains unclear what the immediate outcome of the resolution will be.

The EU has awarded the researchers €188,000 to support the project through September 2026, by which time they hope to have a validated prototype ready.
The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.
Within three years, the project anticipates at least one test for the early-stage detection of Alzheimer's disease could be ready for commercialization.

Two years after the IVDR started taking effect, changes to the regulations, including new deadlines, have meant continued uncertainty for firms and labs.

Driven by New Clinical Trial Data, A3P Biomedical Aims to Grow US Adoption of Prostate Cancer Test
Premium
Called SEPTA, the trial aimed to demonstrate that the firm's Stockholm3 test is accurate in a diverse population of patients.
GMS will also use the funding for studies related to childhood cancer and rare diseases and to continue the development of a National Genomics Platform.